The Venture Challenge is our bi-annual coaching programme. This Spring we will organise the 19th edition. After the…
Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced that it has agreed…
Let us guide you in taking the next steps with your startup. 2017 will offer you the…
We are pleased to send you this special edition of the Health~Holland Update, this magazine features the…
We are pleased to send you the Health~Holland Year in Review 2017, the yearly magazine that reflects…
Recent Comments